Lack of covalent binding to rat liver DNA of the hypolipidemic drugs clofibrate and fenofibrate-Reference-Cited by-同舟云学术

Lack of covalent binding to rat liver DNA of the hypolipidemic drugs clofibrate and fenofibrate

Published:1981-02 Issue:4-5 Volume:7 Page:305-310
ISSN:0378-4274
Container-title:Toxicology Letters
language:en
Short-container-title:Toxicology Letters

Author:

Von Däniken A.,Lutz W.K.,Schlatter C.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference19 articles.

1. Drugs and lipid metabolism: clofibrate;Havel;Annu. Rev. Pharmacol.,1973

2. Tumorigenicity of the hypolipidemic peroxisome proliferator ethyl-α-p-chlorophenoxyisobutyrate (clofibrate) in rats;Reddy;Br. J. Cancer,1979

3. Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drug;Svoboda;Cancer Res.,1979

4. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate;Oliver;Br. Heart J.,1978

5. Antilipidemic drugs, Part 2: Experimental study of a new potent hypolipidemic drug, isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-propionate (LF 178);Gurrieri;Arzneimittel-Forsch.,1976

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative weight of evidence to assess confidence in potential modes of action;Regulatory Toxicology and Pharmacology;2017-06

2. Fenofibrate induces G0/G1 phase arrest by modulating the PPARα/FoxO1/p27kip pathway in human glioblastoma cells;Tumor Biology;2015-01-08

3. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms;European Journal of Cell Biology;2011-08

4. Platelets as a Novel Target for PPAR?? Ligands;BioDrugs;2006

5. Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression.;Environmental Health Perspectives;2004-03